FBI to scrap $5 billion move, Patel says
FBI boss Kash Patel announced on Friday the agency scrapped a $5 billion plan to build a new headquarters.
The FBI will permanently shut down the J. Edgar Hoover building in Washington D.C., and move into the Reagan building near the White House.
“After more than 20 years of failed attempts, we finalized a plan to permanently close the FBI’s Hoover headquarters and move the workforce into a safe, modern facility,” Patel wrote in a post on social media. “Working directly with President Trump and Congress, we accomplished what no one else could.”
Patel said the planned $5 billion renovation that would not be complete until 2035. He said the FBI is already underway with making necessary safety and infrastructure upgrades to the Reagan building.
The U.S. Department of Commerce, U.S. Customs and Border Protection and U.S. Environmental Protection Agency already use spaces in the Reagan building.
The move follows FBI plans to disperse personnel throughout the country, Patel said.
“This decision puts resources where they belong: defending the homeland, crushing violent crime, and protecting national security,” Patel wrote. “It delivers better tools for today’s FBI workforce at a fraction of the cost.”
Latest News Stories
Trump says U.S. in ‘armed conflict’ with drug cartels in Caribbean
Policy experts unimpressed with SBA’s ‘record’ capital delivered to small businesses
City taxpayer burden swells, as Chicago pension debt rises
Poll: Voters like candidates supporting war on Alzheimer’s
U.S. LNG exports at new record in September on strong Louisiana shipments
Conservatives push Union Pacific–Norfolk Southern merger
Hamas agrees to release hostages; demands further negotiations
Report: Bipartisan support for K-12 open enrollment policy
‘End the political idiocy’: Republicans lambast Dems for tanking funding bill again
WATCH: U.S. military strikes another suspected drug boat, killing four
Des Moines Public School system hired superintendent with extensive criminal history
Pro-life group calls FDA’s approval of generic abortion pill ‘unconscionable’